Appointment of new China Distributor
Filed with ASX · · 2 pages · English
Optiscan Imaging Limited on 6ix
Earlier from Optiscan Imaging
- Leading Aus & US Hospital Collaboration to trial OIL device
- Appendix 4E and 2019 Annual Report
- Optiscan System Approved for Prestigious Cancer Centre Trial
- Investor Presentation - June 2019
- Optiscan Secures Strong Support in $1.70 M Capital Raising
Later from Optiscan Imaging
- OIL initiates FDA feedback for Oral Cancer 510(k) submission
- Optiscan Market Update
- 2019 AGM Presentation
- Appointment of Second China Distributor
- Corporate Update - January 2020
Follow Optiscan Imaging into a list and get an email when it puts out news.
Follow Optiscan Imaging